References:
1. Arichi H et al. Effects of stilbene components of the roots of Polygonum cuspidatum...on lipid metabolism. Chem Pharm Bull 1982, 30:1766-70.
2. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-26.
3. Goldberg DM et al. Beyond alcohol: Beverage consumption and cardiovascular mortality. Clin Chim Acta 1995, 237:155-87.
4. Jang M, Cai E, Udeani G et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:2118-220.
5. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004, 22:(3),169-88.
6. Miura D, Miura Y, Yagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci 2003, 73(11):1393-400.
7. Pace-Asciak CR, Hahn S, Dimandis E et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease, Clin Chim Acta 1995, 235:207-19.
8. Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 2004, 36(6):774-81.
9. Hascalik S, Celik O, Turkoz Y, Hascalik M, Cigremis Y, Mizrak B, Yologlu S. Resveratrol, a red wine constituent polyphenol, protects from ischemia-reperfusion damage of the ovaries. Gynecol Obstet Invest 2004, 57:(4):218-23. Epub 2004 Feb 11.
10. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004, 40(1):138-45.
11. Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003, 23(1):17-28.
12. Laux MT, Aregullin M, Berry JP, Flanders JA, Rodriguez E. Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. J Altern Complement Med 2004, 10(2):235-9.
13. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, Choi YH. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 2004, 11(2):441-6.
14. Battout S, Derradji H, Jacquet P, Ooms D, Michaux A, Mergeay M. Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int J Mol Med 2004, 13(6):895-902.
15. Opipari AW Jr, Tan L, Boitano, AE, Sorenson, DR, Aurora, A, Liu JR. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res, 2004 64(2):696-703.
16. Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003, 9(3):408-11.
17. Scifo C, Cardile V, Russo A, Consoli R, Vancheri C, Capasso F, Vanella A, Renis M. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol Res 2004, 14(9):415-26.
18. Kim YA, Rhee SH, Park KY, Choi YH. Antiprolifer-ative effect of resveratrol in human prostate carcinoma cells. J Med Food 2003, 6(4): 273-80.
19. Stewart JR, Artime MC, O’Brian C. Resveratrol: A candidate nutritional substance for prostate cancer prevention. J Nutr 2003, 133:2440S-2443S.
20. Kubota T, Uemura Y, Kobayashi M, Taguchi H., Combined effects of resveratrol and paclitaxel on lung cancer cells. Anticancer Res 2003, 23(5A):4039-46.
21. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 2003, 23(4):255-61.
22. Liontas A, Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 2004, 24(2B): 987-98.
23. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 2003, 190(2):157-63.
24. Fuggetta MP, D’Atri S, Lanzilli G, Tricarico M, Cannavo E, Zambruno G, Falchetti R, Ravagnan G. In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res 2004 14(3):189-96.
25. Kang JH, Park YH, Choi SW, Yang EK, Lee WJ. Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells. Exp Mol Med 2003 35(6):467-74.
26. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anti-Canc Agents 2003, 3(2):77-93.
27. Fu ZD, Cao Y, Wang KF, Xu SF, Han R., [Chemopreventive effect of resveratrol to cancer]. Ai Zheng 2004, 23(8): 869-73.
28. Yu L, Sun ZJ, Wu SL, Pan CE. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 2003, 9(10):2341-3.
29. Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, Pan CE. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 2004, 10(20):3048-52.
30. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY, Chen Y. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 2004, 10(6):2190-202.
31. Gehm B, McAndrews J, Chien P, et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci 1997, 94:138-43.
32. Hao HD, He LR. Mechanisms of cardiovascular protection by resveratrol. J Med Food 2004, 7(3):290-8.
33. Eng ET, Ye J, Williams D, et al. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res 2003, 63:(23)8516-22.
34. Eng ET, Williams D, Mandava U, et al. Anti-aromatase chemicals in red wine. Ann NY Acad Sci 2002, 963:239-46.
35. Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004, 287(4):L774-83. Epub 2004 Jun 04.
36. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, Donnelly LE. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003, 58(11):942-6.
37. Roemer K, Mahyar-Roemer M. The basis for the chemopreventive action of resveratrol. Drugs Today (Barc) 2002, 38(8):571-80.
38. Docherty JJ, Smith JS, Fu MM, Stoner T, Booth T. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Res 2004, 61(1): 19-26.
39. Zhuang H, Kim YS, Koehler RC, Dore S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci 2003, 993:276-86.
40. Wang YJ, He F, Li XL. [Neuroprotection of resveratrol in experimental cerebral ischemia] Zhonghua Yi Xue Za Zhi 2003, 10;83(7):534-6.
41. Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Muller-Spahn F. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 2003, 49(6):380-3.
42. Yang YB, Piao YJ. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 2003, 24(7):703-10.
43. Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004, 141(6):997-1005.
44. Seidman M, Babu S, Tang W, Naem E, Quirk WS. Effects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg 2003, 129(5):463-70.
45. Ferguson LR. Role of plant polyphenols in genomic stability. Mutat Res 2001, 475:89-111.
46. Landryh J et al. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA 2000, 97:5807-5811.
47. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425(6954):191-6. Epub 2003 Aug 24.
48. Jarolim S, Millen J, Heeren G, Laun P, Goldfarb DS, Breitenbach M. A novel assay for replicative lifespan in Saccharomyces cerevisiae. FEMS Yeast Res 2004, 5(2):169-77.
49. Bauer, JH, Goupil, S, Garber, GB, Helfand, SL. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc Natl Acad Sci USA 2004, 101(35): 12980-5. Epub 2004 Aug 24.
50. Goldberg DM, Yan J, Soleas G. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003, 36:79-87.
51. Gescher AJ, Steward WP. Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: A conundrum. Cancer Epidemiology, Biomarkers & Prevention 2003, 12: 953-957.
52.Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis (Lond) 2002, 21:1619-1622.
53. Li Z, Hong T, Shimada Y, Komoto I, Kawabe A, et al. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis (Lond.) 2002, 23:1531-1536.
54. Bannerjee S, Bueso-Ramos C, Aggarwal B. Suppression of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: the role of nuclear factor KB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002, 62:4945-4954.
55. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol Associated Renal Toxicity. Toxicol Sci 2004, Aug 25 [Epub ahead of print].
http://www.vrp.com/newsletterhtml.asp
Other indepth articles appear at: www.YoungAgain.com